A jiffy bag authorized generic drugs price competition Looking ahead to the third quarter, the company expects revenue between $174 million and $179 million and adjusted earnings between 3 cents and 6 cents per share. Analysts expect revenue of $171 million and earnings of 8 cents per share for the quarter, according to FactSet.